Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ArcelorMittal (ADR) (MT), WisdomTree India Earnings Fund (ETF) (EPI) – ETF Alert: Should You Invest in This Emerging Market?

Page 1 of 2

After Posco’s pullout from the multi-billion-dollar steel projects in India, the world’s leading steel maker ArcelorMittal (ADR) (NYSE:MT), has also decided to pull the plug on its Indian investment plan. Posco was gearing up to construct a 6 million ton steel mill while ArcelorMittal was eyeing a project with an annual capacity to produce 12 million tons of steel. Both companies have cited identical reasons: a weak business environment, uncertainty surrounding iron-ore shipments and delays in acquiring land for their respective projects.


ArcelorMittal (ADR) (NYSE:MT)India’s capital markets are represented in nearly a dozen ETFs, but the largest and most popular one is the WisdomTree India Earnings Fund (ETF) (NYSEMKT:EPI). The ETF is one of the worst-performing BRIC-nation funds and has dropped by 19.2% this year.

This ETF offers diversity to investors by allocating 22.8% to its biggest segment, financials, followed by 20.6% to energy and 16.7% to the IT sector. Its three biggest firms, Reliance Industries, Infosys and ONGC, constitute 24.1% of the fund.

The second biggest Indian ETF in terms of assets is the iShares S&P India Nifty 50 Index, which focuses on the 50-biggest Indian firms. This ETF is a relatively safer investment due to its concentration on large-cap stocks. It offers a higher yield than Wisdom Tree India Earnings Fund but it is more expensive as it charges a higher expense ratio and has a larger P/E. It allocated 26.5% of its assets to financials while its three biggest holdings; ITC, Infosys and Reliance Industries, represent 25.7% of the fund.

Exp Ratio 0.83% 0.92%
Total Assets $688,248,270 $415,188,404
Top Firm Reliance Industries Ltd (9.54%) ITC Ltd (10.21%)
Top Sector Financials (22.76%) Financials (26.52%)
Yield 1.07% 1.29%
P/E 10 14

Blow to Indian foreign investment

Posco and ArcelorMittal (ADR) (NYSE:MT) represent two of the biggest foreign investment plans in the country and therefore their pullout is a big blow to the government’s efforts, which have been targeting an economic revival by luring overseas capital. Moreover, the country was also aiming to treble its steel capacity from 100 million tons in 2013 to 300 million tons by 2025 but with the cancellation of significant projects, weak investor confidence and the country’s economic woes (discussed later), we can safely assume that India is not going to touch its 2025 target.

Posco and ArcelorMittal (ADR) (NYSE:MT)’s withdrawal highlights the rampant red-tape in the government departments and a lack of a clear environmental policy, which cause significant delays in the implementation of projects.

ArcelorMittal (ADR) (NYSE:MT) has been struggling due to the weakness in steel demand, particularly from Europe; and I believe that this is also one of the main reasons why the company scrapped its Indian steel-mill plans. The slowdown in the Chinese and European economies is preventing any turnaround of steel prices. This year, in China and Europe, steel prices have tumbled by 14% and 11%, respectively. ArcelorMittal has been one of the hardest hit due to its significant exposure to the debt-ridden continent of Europe. The company is selling assets and shutting down blast furnaces to cut down cost.

On August 1, ArcelorMittal (ADR) (NYSE:MT) reported its quarterly results in which it swung to a net loss of $780 million from a profit of $1 billion a year ago, and significantly worse than market’s expectations of a profit of $117 million. Its sales dropped by 10% to $20.2 billion while shipments fell 1.8% to 21.7 million metric tons. Once again, Europe has remained its weak spot. Its shares have fallen by 25.8% since January and I believe that it will continue to under-perform this year. The company will be an interesting play when we start seeing signs of improvement from Europe and China, but for now, I would rather stay on the sidelines.

Economic woes

India’s economic growth has been slowing down at an alarming rate as the growth levels touched a 10-year low of 5% for the fiscal year ending March 2013. The private consumption has been weak, capital spending has been low and the public expenditure is slowing down; as a result, there are little-to-no chances of a quick economic rebound in the coming quarters.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!